Cochlear Ltd (ASX: COH) is one of the world’s leading medical businesses. Cochlear designs, manufactures and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant. Graeme Clark invented the first device in 1982, allowing first-user Graham Carrick to hear for the first time for 17 years. Some of the most recent modifications allow users to play sound from their phone directly into their implant.
The Cochlear Limited share price has been unstoppable this year – up nearly 30% since the beginning of 2021. Here’s the latest on Cochlear.
Want to start ethical investing? Ever thought about ethical investing in Australia? Just like me you can start today by following just 5 simple ethical steps.
There are some quality ASX tech shares that Aussies can buy for their portfolios. I believe they could be buys today for the next decade.
The S&P/ASX 200 (INDEXASX:XJO) is set to open slightly lower on Monday. Cochlear (ASX:COH), QBE (ASX:QBE) and Shaver Shop (ASX:SSG) shares are in the news.
The Cochlear Limited (ASX:COH) share price will be in focus after the hearing device business said its underlying profit fell. It’s expecting growth in FY21 H2.
The ETF in this article could be an effective way to diversify your ASX share portfolio. It’s BetaShares Australian Ex-20 Portfolio Diversifier ETF (ASX:EX20).
The S&P/ASX 200 (INDEXASX:XJO) is expected to edge higher when the market opens this morning. BHP Group (ASX:BHP) and Afterpay (ASX:APT) shares are in the news.
Cochlear Limited (ASX:COH) shares are up after the hearing device business announced its FY21 first quarter update.
The Cochlear Limited (ASX: COH) share price is just over 20% below its 2020 high. Is now the time to go shopping?
